Role of fat and the n-3 polyunsaturated fatty acids family in the prevention and treatment of diabetes mellitus - a review

• Autorzy: Grygiel-Gorniak B. , McEneny J. , Linke K. , Przyslawski J.
• Języki publikacji: EN

Abstrakty

EN

Type 2 diabetes mellitus is a world wide problem, with obesity being a primary risk factor of this disease, mainly caused by poor diet and lack of physical activity. In the diet of subjects with diabetes, it is not only the quantity but also the quality of fat ingested that appears to be of great importance. Presented in this article is a review of the role of nutritional fat on insulin signaling and its risk involvement in diabetes mellitus.

• Wydawca: -
• Czasopismo: Polish Journal of Food and Nutrition Sciences
• Rocznik: 2010
• Tom: 60
• Numer: 2
• Opis fizyczny: p.99-105,ref.

Twórcy

autor

Grygiel-Gorniak B.

• Department of Bromatology and Human Nutrition, Poznan University of Medical Sciences, Marcelinska Str. 42, 60-354 Poznan, Poland

autor

McEneny J.

autor

Linke K.

autor

Przyslawski J.

Bibliografia

• 1. Abel E.D., Glucose transport in the heart. Frontiers in Bioscience, 2004, 9, 201–215.
• 2. ADA, American Diabetes Association. Screening for Diabetes. Diabetes Care, 2002, 25, S21–S24.
• 3. ADA, American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2004, 27, 5–10.
• 4. Ascherio A., Katan M.B., Zock P.L., Stampfer M.J., Willett W.C., Trans fatty acids and coronary heart disease. N. Engl. J. Med., 1999, 340, 1994–1998.
• 5. Avogaro A., Insulin resistance: trigger or concomitant factor in the metabolic syndrome. Panminerva Med., 2006, 48, 3–12.
• 6. Baur L.A., O’Connor J., Pan D.A., Storlien L.H., Relationships between maternal risk of insulin resistance and the child’s muscle membrane fatty acid composition. Diabetes, 1999, 48, 112–116.
• 7. Boden G., Effects of free fatty acids on glucose metabolism: significance for insulin resistance and Type 2 Diabetes. Exp. Clin. Endocrinol. Diab., 2003, 111, 121–24.
• 8. Bray G.A., Lovejoy J.C., Smith S.R., DeLany J.P., Lefevre M., Hwang D., Ryan D.H., York D.A., The influence of different fats and fatty acids on obesity, insulin resistance and inflammation. J. Nutr., 2002, 132, 2488–2491.
• 9. Chambrier C., Bastard J.P., Rieusset J., Chevillotte E., Bonnefont- Rousselot E., Therond P., Hainque B., Riou J.P., Laville M., Vidal H., Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor γ. Obesity Res., 2002, 10, 518–525.
• 10. Clamp A.G., Ladha S., Clark D.C., Grimble R.F., Lund E.K., The influence of dietary lipids on the composition and membrane fluidity of the rat hepatocyte plasma membrane. Lipids, 1997, 32, 179–184.
• 11. Colditz G.A., Willett W.C., Rotnitzky A., Manson J.E., Weight gain as a risk factor for clinical diabetes in women. Ann. Intern. Med., 1995, 122, 481–486.
• 12. de Lorgeril M., Salen P., Martin J.L., Monjaud I., Delaye J., Mamelle N., Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. Circulation, 1999, 99, 779–785.
• 13. Delarue J., LeFoll C., Corporeau C., Lucas D., N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod. Nutr. Dev., 2004, 44, 3, 289–299.
• 14. Doucet E., Alméras N., White M.D., Després J.P., Bouchard C., Tremblay A., Dietary fat composition and human adiposity. Eur. J. Clin. Nutr., 1998, 52, 2–6.
• 15. Durrington P., Bhatnagar D., Mackness M., Morgan J., Julier K., Khan M., France M., An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridemia. Heart, 2001, 85, 544–548.
• 16. Ebbesson S.O., Risica P.M., Ebbesson L.O., Kennish J.M., Tejero M.E., Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int. J. Circumpolar. Health, 2005, 64, 396–408.
• 17. Feskens E.J., Virtanen S.M., Räsänen L., Tuomilehto J., Stengård J., Pekkanen J., Nissinen A., Kromhout D., Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow- up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care, 1995, 18, 1104–1112.
• 18. Feskens E.J., van Dam R.M., Dietary fat and the etiology of type 2 diabetes: an epidemiological perspective. Nutr. Metab. Cardiovasc. Dis., 1999, 9, 87–95.
• 19. Fickova M., Hubert P., Cremel G., Leray C., Dietary (n-3), and (n-6) poly-unsaturated fatty acids rapidly modify acid composition and insulin effects in rat adipocytes. J. Nutr., 1998, 128, 512–519.
• 20. Gibney H.J., Elia M., Ljungqvist O. et al., Clinical Nutrition. 2005, Blackwell, Oxford.
• 21. Haag M., Dippenaar N., Dietary fats, fatty acids and insulin resistance: short review of a multifaceted connection. Med. Sci. Monit., 2005, 11, 359–367.
• 22. Harding A.H., Day N.E., Khaw K.T., Bingham S., Luben R., Welsh A., Wareham N.J., Dietary fat and the risk of clinical type 2 diabetes/ The European Prospective Investigation of Cancer‑Norfolk Study. Am. J. Epidemiol., 2004, 159, 73–82.
• 23. Harding A.H., Sargeant L.A., Welch A., Oakes S., Luben R.N., Bingham S., Day N.E., Khaw K.T., Wareham N.J., Fat consumption and HbA1c levels: the EPIC-Norfolk Study. Diabetes Care, 2001, 24, 1911–1916.
• 24. Heini A.F., Weinsier R.L., Divergent trends in obesity and fat intake patterns: the American paradox. Am. J. Med., 1997, 102, 259–264.
• 25. Homko C.J., Cheung P., Boden G., Effects of free fatty acids on glucose uptake and utilization in healthy women. Diabetes, 2003, 52, 487–491.
• 26. Hu F.B., Manson J.E., Stampfer M.J., Colditz G., Liu S., Solomon C.G., Willett W.C., Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med., 2001, 345, 790–797.
• 27. Hu F.B., Stampfer M.J., Manson J.E., Rimm E., Colditz G.A., Rosner B.A., Hennekens C.H., Willett W.C., Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med. 1997, 337, 1491–1499.
• 28. Hulbert A.J., Turner N., Storlien L.H., Else P.L., Dietary fats and membrane function: implications for metabolism and disease. Biol. Rev. Cambridge Philosophical Soc., 2005, 80, 155–169.
• 29. Ide T., Tsunoda M., Mochizuki T., Murakami K., Enhancement of insulin signalling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) a in obese mice. Med. Sci. Monit., 2004, 10, 388–395.
• 30. Jarvinen R., Knekt P., Rissanen H., Reunanen A., Intake of fish and long-chain n-3 fatty acids and the risk of coronary heart mortality in men and women. Br. J. Nutr., 2006, 95, 824–829.
• 31. Jucker B.M., Cline G.W., Barucci N., Shulman G.I., Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle. Diabetes, 1999, 48, 134–140.
• 32. Julius U., Fat modification in the diabetes diet. Exp. Clin. Endocrinol. Diabetes, 2003, 111, 2, 60–65.
• 33. Kahn B.B., Pedersen O., Suppression of GLUT4 expression in skeletal muscle of rats that are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity. Endocrinology, 1993, 132, 13–22.
• 34. Kemper H.C., Stasse-Wolthuis M., Bosman W., The prevention and treatment of overweight and obesity. Summary of the advisory report by the Health Council of The Netherlands. Neth. J. Med., 2004, 62, 10–17.
• 35. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., Lehmann J.M., Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA, 1997, 94, 4318– 4323.
• 36. Kratz M., von Eckardstein A., Fobker M., Buyken A., Posny N., Schulte H., Assmann G., Wahrburg U., The impact of dietary fat composition on serum leptin concentrations in healthy nonobese men and women. J. Clin. Endocrin. Metabol., 2002, 87, 5008–5014.
• 37. Leonetti D.L., Tsunehara C.H., Wahl P.W., Fujimoto W.Y., Baseline dietary intake and physical activity of Japanese American men in relation to glucose intolerance at 5-year follow-up. Am. J. Hum. Biol., 1996, 8, 55–67.
• 38. Liu S., Choi H.K., Ford E., Yiqing Song Y., Klevak A., Buring J.E., Manson J.E., A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care, 2006, 29, 1579–1584.
• 39. Long S.D., Pekala P.H., Regulation of GLUT4 gene expression by arachidonic acid. J. Biol. Chem., 1996, 271, 1138–1144.
• 40. Lovejoy J., The influence of dietary fat on insulin resistance. Curr. Diab. Rep., 2002, 2, 435–440.
• 41. Lundgren H., Bengtsson C., Blohmé G., Isaksson B., Lapidus L., Lenner R.A., Saaek A., Winther E., Dietary habits and incidence of non-insulin-dependent diabetes mellitus in a population study of women in Gothenburg, Sweden. Am. J. Clin. Nutr., 1989, 49, 708–712.
• 42. Mayer-Davis E., Monaco J., Hoen H., Carmichael S., Vitolins M., Rewers M., Haffner S., Ayad M., Bergman R., Karter A., Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS) Am. J. Clin. Nutr., 1997, 65, 1, 79–87.
• 43. McGarry J.D., Dysregulation of fatty acid metabolism in the etiology of Type 2 Diabetes. Diabetes, 2002, 51, 7–18.
• 44. Mostad I.L., Qvigstad E., Bjerve K.S., Grill V.E., Effects of a 3-day low-fat diet on metabolic control, insulin sensitivity, lipids and adipocyte hormones in Norwegian subjects with hypertriacylglycerolaemia and type 2 diabetes. Scand. J. Clin. Lab. Invest., 2004, 64, 565–574.
• 45. Nettleton J.A., Katz R., n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J. Am. Diet Assoc., 2005, 105, 3, 428–440.
• 46. Oakes N.D., Cooney G.J., Camilleri S., Chisholm D.J., Kraegen E.W., Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes, 1997, 46, 1768–1774.
• 47. Oliver M.F., It is more important to increase the intake of unsaturated fats than to decrease the intake of saturated fats: evidence from clinical trials relating to ischemic heart disease. Am. J. Clin. Nutr., 1997, 66(suppl), 980S–986S.
• 48. Panagiotakos D.B., Pitsavos C., Polychronopoulos E., Chrysohoou C., Zampelas A., Trichopoulou A., Can a Mediterranean diet moderate the development and clinical progression of coronary heart disease? A systematic review. Med. Sci. Monit., 2004, 10, RA193–198.
• 49. Parillo M., Rivellese A.A., Ciardullo A.V., Capaldo B., Giacco A., Genovese S., Riccardi G., A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism, 1992, 41, 1373–1378.
• 50. Pérez-Jiménez F., López-Miranda J., Pinillos M.D., Gómez P., Paz-Rojas E., Montilla P., Marín C., Velasco M.J., Blanco‑Molina A., Jiménez Perepérez J.A., Ordovás J.M., A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia, 2001, 44, 2038–2043.
• 51. Petersen K.F., Shulman G.I., Pathogenesis of skeletal muscle insulin resistance in Type 2 Diabetes Mellitus. Am. J. Cardiol., 2002, 90(suppl), 11–18G.
• 52. Price P.T., Nelson C.M., Clarke S.D., Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr. Opin. Lipidol., 2000, 11, 3–7.
• 53. Proietto J., Mechanisms of insulin resistance caused by nutrient toxicity. Hepatol. Res. 2005, 33, 87–91.
• 54. Pryor P.R., Liu S.C., Clark A.E., Yang J., Holman G.D., Tosh D., Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin. Biochem J., 2000, 15, 83–91.
• 55. Salmerón J., Hu F.B., Manson J.E., Stampfer M.J., Colditz G.A., Rimm E.B., Willett W.C., Dietary fat intake and risk of type 2 diabetes in women. Am. J. Clin. Nutr., 2001, 73, 1019–1026.
• 56. Sanders T.A., Gleason K., Griffin B., Miller G.J., Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6n-3) and docosapentaenoic acid (22:5n-6) on cardiovascular risk factors in healthy men and women. Br. J. Nutr., 2006, 95, 525–531.
• 57. Sethi S., Ziouzenkova O., Ni H., Wagner D.D., Plutzky J., Mayadas T.N., Oxidized omega-3 fatty acids in fish oil inhibit leukocyte- endothelial interactions through activation of PPAR alpha. Blood, 2002, 15, 1340–1346.
• 58. Simopoulos A.P., Evolutionary aspects of diet, essential fatty acids and cardiovascular disease. J. Heart J., 2001, Suppl3, 8–21.
• 59. Skrha J., Kunesova M., Hilgertova J., Weiserova H., Krizova J., Kotrlikova E., Short-term very low calorie diet reduces oxidative stress in obese type 2 diabetic patients. Physiol. Res., 2005, 54,33–39.
• 60. Storlien L.H., Jenkins A.B., Chisholm D.J., Pascoe W.S., Khouri S., Kraegen E.W., Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes, 1991, 40, 280–289.
• 61. Summers L.K., Fielding B.A., Bradshaw H.A., Ilic V., Beysen C., Clark M.L., Moore N.R., Frayn K.N., Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia, 2002, 45, 369–377.
• 62. Taouis M., Dagou C., Ster C., Durand G., Pinault M., Delarue J., N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle. Am. J. Physiol. Endocrinol. Metab., 2002, 282, 3, 664–671.
• 63. Tontonoz P., Hu E., Graves R.A., Budavari A.I., Spiegelman B.M., mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev., 1994, 8, 1224–1234.
• 64. Trichopoulou A., Orfanos P., Norat T., Bueno-de-Mesquita B., Ocké M.C., Peeters P.H., van der Schouw Y.T., Boeing H, Hoffmann K., Boffetta P., Nagel G., Masala G., Krogh V., Panico S., Tumino R., Vineis P., Bamia C., Naska A., Benetou V., Ferrari P., Slimani N., Pera G., Martinez-Garcia C., Navarro C., Rodriguez-Barranco M., Dorronsoro M., Spencer E.A., Key T.J., Bingham S., Khaw K.T., Kesse E., Clavel-Chapelon F., Boutron-Ruault M.C., Berglund G., Wirfalt E., Hallmans G., Johansson I., Tjonneland A., Olsen A., Overvad K., Hundborg H.H., Riboli E., Trichopoulos D., Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ, 2005, 330, 991.
• 65. van de Laar F.A., van de Lisdonk E.H., Lucassen P.L., Tigchelaar J.M.H., Meyboom S., Mulder J., van den Hoogen H., Rutten G.E., van Weel C., Fat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice. Br. J. Gen. Pract., 2004, 54, 177–182.
• 66. Vessby B., Unsitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., Nälsén C., Berglund L., Louheranta A., Rasmussen B.M., Calvert G.D., Maffetone A., Pedersen E., Gustafsson I.B., Storlien L.H., Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia, 2001, 44, 312–319.
• 67. Wang H., Storlien L.H., Huang X.F., Influence of dietary fats on c-Fos-like immunoreactivity in mouse hypothalamus. Brain Res., 1999, 843, 184–192.
• 68. WHO, Word Health Organization. Diet, nutrition and chronic diseases. WHO Technical Repost Series 916. Geneva 2003a.
• 69. WHO, Word Health Organization. Obesity: preventing and managing the global epidemic. World Health Organ Tech. Rep. Ser., 2000 894, i-xii, 1–253.
• 70. WHO, World Health Organization: Integrated prevention of noncommunicable diseases. Draft global strategy on diet, physical activity and health. Geneva 2003b.
• 71. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes. Diabetes Care, 2004, 27, 1047–1053.
• 72. Wilkes J.J., Bonen A., Bell R.C., A modified high-fat diet induces insulin resistance in rat skeletal muscle but not in adipocytes. Am. J. Physiol., 1998, 275, 679–686.
• 73. Ye J.M., Doyle p.J., Iglesias M.A., Watson D.G., Cooney G.J., Kraegen E.W., Peroxisome Proliferator—Activated Receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat—fed rats comparison with PPAR-γ activation. Diabetes, 2001, 50, 411–417.
• 74. Zierath J.R., Houseknecht K.L., Gnudi L., Kahn B.B., High‑fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes, 1997, 46, 215–223.

Uwagi

PL

Rekord w opracowaniu